This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Taylor, D. Articles by Walwyn, R. Search for Related Content PubMed PubMed Citation Articles by Taylor, D. Articles by Walwyn, R. Social Bookmarking                         What's this?

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs

Pharmacy Department, Maudsley Hospital, London, UK, david.taylor{at}slam.nhs.uk

Corina Young

Pharmacy Department, Maudsley Hospital, London, UK

Radia Mohamed

Pharmacy Department, Bexley Hospital, Bexley, UK

Carol Paton

Pharmacy Department, Bexley Hospital, Bexley, UK

Rebecca Walwyn

Clinical Trials Unit, Institute of Psychiatry, King’s College London, London, UK

The associations between psychosis, antipsychotic drugs and diabetes mellitus have not been precisely defined but it has been repeatedly suggested that atypical antipsychotics are more likely to give rise to diabetes than are conventional drugs. This belief is largely based on healthcare database analyses which, in part, rely on the assumption that all cases of diabetes are identified in practice. We examined records of 606 hospitalized patients receiving antipsychotic treatment and found an apparent prevalence of diabetes and impaired fasting glucose of 6.4%. From this sample of patients, we investigated 166 patients (fasting blood samples) who were not known to have any disorder of glucose homeostasis and identified 10 cases of impaired fasting glucose and nine cases of diabetes mellitus (11.4% of those tested). Nine of these cases had documented evidence of previous testing for diabetes. Apparent prevalence of diabetes and impaired fasting glucose was 16.9% in those tested in practice or the study. Diagnosis was significantly associated with age [odds ratio (OR) 1.02] and treatment duration with current drug (OR 1.01). Adjusted ORs of diagnosis were not significantly different for any atypical antipsychotic compared with conventional drugs. It is concluded that there was a clinically significant prevalence of undiagnosed diabetes and impaired fasting glucose in those individuals receiving antipsychotics. Importantly, database analyses may underestimate the true prevalence of diabetes in similar populations and erroneously ascribe increased risk to certain drug treatments.

Key Words: antipsychotics • diabetes mellitus • impaired fasting glucose • prevalence

Journal of Psychopharmacology, Vol. 19, No. 2, 182-186 (2005)
DOI: 10.1177/0269881105049039


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Taylor Antipsychotic polypharmacy - confusion reigns The Psychiatrist, February 1, 2010; 34(2): 41 - 43. [Abstract] [Full Text] [PDF]

				T. R. E. Barnes, C. Paton, M.-R. Cavanagh, E. Hancock, D. M. Taylor, and on behalf of the UK Prescribing Observatory for Me A UK Audit of Screening for the Metabolic Side Effects of Antipsychotics in Community Patients Schizophr Bull, November 1, 2007; 33(6): 1397 - 1403. [Abstract] [Full Text] [PDF]

				A.H. Barnett, P. Mackin, I. Chaudhry, A. Farooqi, R. Gadsby, A. Heald, J. Hill, H. Millar, R. Peveler, A. Rees, et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia J Psychopharmacol, June 1, 2007; 21(4): 357 - 373. [Abstract] [PDF]

				R. I. Holt Review: Severe mental illness, antipsychotic drugs and the metabolic syndrome The British Journal of Diabetes & Vascular Disease, September 1, 2006; 6(5): 199 - 204. [Abstract] [PDF]

				R. I. G. Holt, C. Bushe, and L. Citrome Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol, November 1, 2005; 19(6_suppl): 56 - 65. [Abstract] [PDF]